Cargando…
DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases
BACKGROUND & AIMS: DNA ploidy, a DNA flow cytometry parameter, reflects tumor cell cycle. In breast cancer (BC), ploidy status characterizes genotypic stability and potential metastatic capacity. It is suggested that aneuploidy is an independent prognosticator for BC patients and could aid for i...
Autores principales: | Xu, Jing, Huang, Lei, Li, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312380/ https://www.ncbi.nlm.nih.gov/pubmed/27528028 http://dx.doi.org/10.18632/oncotarget.11130 |
Ejemplares similares
-
DNA aneuploidy in early breast cancer.
por: Ottesen, G. L., et al.
Publicado: (1995) -
Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases
por: Xu, Jing, et al.
Publicado: (2019) -
Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10)
por: Comi, Michela, et al.
Publicado: (2019) -
CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis
por: Ni, Chao, et al.
Publicado: (2019) -
DNA aneuploidy in colorectal adenomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)